Email Updates

You are here

HPTN 078

Status
Completed
Phase
Other
Principal Investigator(s)
Chris Beyrer
Objective

 

The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable interventions to identify, recruit, link to care, retain in care, attain, and maintain viral suppression among HIV-infected men who have sex with men (MSM) in the United States (US).

This study will use deep-chain respondent driven sampling (DC-RDS) and direct recruitment (DR) to identify and recruit HIV-infected MSM who are not virally suppressed. A subset of these men will be enrolled into one of two study arms. The intervention arm will provide a Case Manager (CM) intervention package designed to enhance linkage to care, antiretroviral treatment (ART) initiation, treatment adherence and retention in care. The control arm will provide the standard of care (SOC) for linkage to care, initiation of ART, treatment adherence and retention in care. The primary outcome of the study is viral suppression 12 months after enrollment. Phylogenetic methods will be used to evaluate the relationship between viruses in study participants. Mathematical modeling will be performed using demographic, behavioral, and clinical data generated from this study and other sources to estimate the population-level impact of the CM intervention on HIV incidence and to estimate the level of identification, linkage, ART coverage and viral suppression that would be required to achieve a substantial reduction in HIV incidence among MSM in the US settings where the study is conducted.

 

See here for more details on the HPTN study website.

Last updated June 10, 2022

Prevention Option(s)
General
Treatment
Study Design
Randomized
Open label
Arms and Assigned Interventions
Description
Experimental: Intervention The intervention arm will provide a Case Manager (CM) intervention package designed to enhance linkage to care, antiretroviral treatment (ART) initiation, treatment adherence and retention in care.
ARMs
Experimental
Description
The control arm used the SOC for linkage to care, ART adherence and retention in care. The study team compared how well the intervention and SOC arms achieved viral suppression 12 months after enrollment.
ARMs
Placebo Comparator
Trial Sponsors
NIAID (DAIDS ID: 11995)
June 2016
February 2019
Enrollment
144
16
Years
Population
HIV positive
MSM
Sites

Alabama Vaccine CRS

Birmingham, Alabama
United States of America

Fenway Health (FH) CRS

Boston, Massachusetts
United States of America

Johns Hopkins Adult AIDS CRS

Baltimore, Maryland
United States of America

Ponce de Leon

Atlanta, Georgia
United States of America